- A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study. Falkson, G., Cnaan, A., Simson, I.W., Dayal, Y., Falkson, H., Smith, T.J., Haller, D.G. Am. J. Clin. Oncol. (1990)